News

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
FDA approves 6-month HIV prevention shot
Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...
FDA announces sweeping changes to speed up the drug review process
An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...
FDA: Children’s cough syrup sold nationwide recalled over potential microbial contamination
The affected products were distributed nationwide through retailers and online from Dec. 14, 2022, through June 4, 2025, the ...
Little Remedies Honey Cough Syrup recalled over safety concerns
The recall affects 4 oz. bottles of the natural cough syrup distributed across the United States between December 2022 and ...
Agence France-Presse on MSN25m
US approves Gilead's twice-yearly injection to prevent HIV
The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move ...
Bridge Michigan19m
Back from DC, Michigan GOP leader backs Medicaid, food assistance cuts
Michigan House Speaker Matt Hall ‘very supportive’ of federal proposals to curb federal spending on health and food ...